Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
General24 hours agoOne man dead, another seriously injured in shooting outside Forest Lodge pub in Sydney’s inner-city
-
Noosa News16 hours agoWhy buying a home in this surprise suburb could save you $400,000
-
Business13 hours agoBell Potter names cheap ASX dividend shares to buy now
-
Noosa News14 hours agoUncertainty still surrounds government pay deals with police, teachers, and nurses and midwives